Sveikatal's development program can be divided into two areas:
Therapy for metabolic disorders is based on our discovery that drugs that
activate a specific retinoid receptor reverse type 2 diabetes and treat a variety of metabolic disorders, including fatty liver disease.
Therapy for head and neck cancer (oral cancer) builds on our discovery that
treatment with a combination of two drugs that act on two different retinoid receptors reduces the occurrence of head and neck cancer.